Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |